Difference between revisions of "Part:BBa K4960024"
| Line 13: | Line 13: | ||
<p><strong>Usage and Biology</strong></p> | <p><strong>Usage and Biology</strong></p> | ||
<p>Introduce enzymatic cleavage sites required by the Golden Gate assembly method to test the effect of linkers with different structures on the structure of nonapeptide and tail filament protein. And then predicted the optimal display conditions for CKGGRAKDC by modeling.</p> | <p>Introduce enzymatic cleavage sites required by the Golden Gate assembly method to test the effect of linkers with different structures on the structure of nonapeptide and tail filament protein. And then predicted the optimal display conditions for CKGGRAKDC by modeling.</p> | ||
| − | <html> | + | </html> |
<!-- --> | <!-- --> | ||
<span class='h3bb'>Sequence and Features</span> | <span class='h3bb'>Sequence and Features</span> | ||
Revision as of 17:24, 10 October 2023
pvc13 NTD-2*Bsal-pvc13 CTD
A sequence used to introduce the BsaI digestion site.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 309
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]